Company Filing History:
1 out of 328 
1 out of 559 
Years Active: 2021
Title: Natalia Curado: Innovator in Antibody-Drug Conjugates
Introduction
Natalia Curado is a prominent inventor based in Brooklyn, NY (US). She has made significant contributions to the field of biochemistry, particularly in the development of antibody-drug conjugates (ADCs). Her innovative work focuses on enhancing cancer treatment options, specifically for breast cancer.
Latest Patents
Natalia Curado holds a patent for "Antibody-drug conjugates based on gold compounds." This patent describes ADCs that have a specific structure where L is a PR ligand. The ADCs feature n drug moieties bound to the Trastuzumab antibody, achieving a drug-to-antibody ratio (DAR) between 2 and 4. The drug moieties are connected to the Trastuzumab antibody through cysteine (S) or lysine (Lys) residues. These ADCs are particularly useful in treating breast cancer, showcasing her commitment to advancing medical therapies.
Career Highlights
Throughout her career, Natalia has worked with esteemed institutions such as the City University of New York and Memorial Sloan Kettering Cancer Center. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of her notable coworkers include Maria Contel and Jason S. Lewis. Their collaborative efforts have furthered the development of innovative solutions in cancer treatment.
Conclusion
Natalia Curado's work in the field of antibody-drug conjugates represents a significant advancement in cancer therapy. Her dedication to innovation and collaboration continues to impact the medical community positively.